Key result
All antidepressants carry cardiovascular risks including orthostatic hypotension and conduction delay.
Why the study?
What are the cardiovascular toxicities associated with standard and newer antidepressant medications?
What are the cardiovascular toxicities associated with standard and newer antidepressant medications?
This review highlights that all currently available antidepressant medications carry some cardiovascular risk, necessitating caution especially in patients with heart failure or conduction disease.
Answers are grounded in this paper and cite their sources.
Patients with HF or conduction delay face orthostatic and proarrhythmic TCA risks; leaves open comparative safety of newer agents in contemporary cardiac cohorts.
This article reviews the cardiovascular effects of the standard tricyclic antidepressant agents and the cardiovascular effects of the newer antidepressant drugs. The cardiovascular effects of the standard tricyclic agents are orthostatic hypotension, conduction delay, and a potent antiarrhythmic effect. Patients with congestive heart failure receiving cardiac medications are at greatly increased risk for orthostatic hypotension, while patients with preexisting conduction delay are at risk for heart block. Of the newer antidepressant drugs, mianserin, nomifensine, and bupropion initially appeared to be most promising in terms of cardiovascular effects, but subsequently proved to have other serious liabilities; these agents require further testing. Trazodone has emerged as the antidepressant drug with the least risk of death in overdose, and as a useful alternative to the standard tricyclic antidepressant drugs in patients with preexisting conduction disease. However, trazodone therapy has been associated with some adverse effects, and, therefore, from the data presented in this paper, it can be concluded that no drug currently available is without some cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Jackson et al. (2010) conducted a review in Cardiovascular toxicity of antidepressants. Antidepressant medications was evaluated. Antidepressant medications, including tricyclic and newer agents, carry cardiovascular risks such as orthostatic hypotension and conduction delay, with no drug being entirely without risk.
Synapse has enriched 10 related papers. Consider them for comparative context: